Cancer clinical trials in the region Auvergne-Rhône-Alpes

292 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes

Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT05592626 #2023-505334-10-00
Locally Advanced Metastatic MSI/dMMR 1 2 3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2 Lung cancer #NCT06162572 #2023-508730-34-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR ROS-1 Immunotherapy Immunotherapy
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Servier
Phase 1 / Phase 2 Lung cancer #NCT04626635 #2022-501234-37-00
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive Immunotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals
Phase 1 / Phase 2 Lung cancer #NCT05592626 #2023-505334-10-00
NSCLC (Non-Small Cell Lung Cancer) Metastatic MSI/dMMR 1 2 3 or more
Centre Léon Bérard (Lyon)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2 Lung cancer #NCT05751798 #2024-514826-22-00
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR ROS-1 Immunotherapy Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 1 / Phase 2 Endometrial cancer #NCT04008797 #2023-510275-64-00
Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy
Systemic Treatment-Naive
Hôpital de la Croix Rousse - Hospices Civils de Lyon (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand )
Eisai Inc.
Phase 1 / Phase 2 Breast cancer Prostate cancer #NCT05592626 #2023-505334-10-00
HER2 Negative HR Negative Locally Advanced Metastatic Metastatic Castration-resistant MSI/dMMR 1 2 3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT04956640
Locally Advanced Metastatic KRAS G12C 1 2 3 or more Chemotherapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Eli Lilly et compagnie
Phase 1 / Phase 2 Lung cancer #NCT06162221
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic KRAS G12D 1 2 3 or more
Systemic Treatment-Naive Systemic Treatment-Naive
Hôpital Louis Pradel (Bron )
Revolution Medicines, Inc.
Phase 1 / Phase 2 Endometrial cancer #NCT04956640
Locally Advanced Metastatic KRAS G12C 1 2 3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Eli Lilly et compagnie